7 issue 5 the distribution of mutations and in the pattern of mutational events when compared to tumors indicating that they are representative of the cells from which they were derived.
P53 status in cancer cell lines.
This special issue on tp53 propels the tp53 gene into the post genomic era.
Knowledgebase and statistical tools for the analysis of tp53 gene mutations in human cancers.
Using the nci 60 cell line panel as a model widely used in the literature the p53 status could not be ascertained for 13 cell lines due to a lack of homogeneous data in the literature.
Several fundamental features of wild type and mutant proteins and their modifications are reviewed as well as animal models and clinical aspects such as recommendations for patient care.
The tp53 gene network in the post genomic era.
Since then a large number of publications have demonstrated many gofs in numerous cell lines with a variety of p53 mutations summarized in table 1 the gof acquired by mutant p53 is further supported by the finding that patients carrying a tp53 missense mutation leading to expression of a.
The current version includes 2 000 and 500 cell lines with mutant tp53 and wild type tp53 respectively.
When the introduction of mutant p53 into p53 null cells was shown to give rise to a new phenotype.
The p53 mutations in cell lines compendium.
P53 mutation status in human cancer cell lines 700 cancer biology therapy 2008.